PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients ; volume:55 ; number:3 ; year:2024 ; pages:380-388 ; extent:9
American journal of nephrology ; 55, Heft 3 (2024), 380-388 (gesamt 9)

Creator: Ali, Hamad
Alahmad, Barrak
Senum, Sarah R.
Warsame, Samia
Bahbahani, Yousif
Abu-Farha, Mohamed
Abubaker, Jehad
Alqaddoumi, Malak
Al-Mulla, Fahd
Harris, Peter C.

DOI: 10.1159/000536165

URN: urn:nbn:de:101:1-2406130014446.850689269142

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ali, Hamad
Alahmad, Barrak
Senum, Sarah R.
Warsame, Samia
Bahbahani, Yousif
Abu-Farha, Mohamed
Abubaker, Jehad
Alqaddoumi, Malak
Al-Mulla, Fahd
Harris, Peter C.

Other Objects (12)

Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method

Konferenzschrift | Kongress

Autosomal dominant polycystic kidney disease : 39 tables

Autosomal dominant polycystic kidney disease in Colombia

Echocardiographic characteristics of autosomal dominant polycystic kidney disease

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes

Early clinical management of autosomal recessive polycystic kidney disease

Urine proteome of autosomal dominant polycystic kidney disease patients

Hochschulschrift

The polycystin signalling cascade in autosomal dominant polycystic kidney disease

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)

Mortality risk in patients with autosomal dominant polycystic kidney disease

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method

Konferenzschrift | Kongress

Autosomal dominant polycystic kidney disease : 39 tables

Autosomal dominant polycystic kidney disease in Colombia

Echocardiographic characteristics of autosomal dominant polycystic kidney disease

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes

Early clinical management of autosomal recessive polycystic kidney disease

Urine proteome of autosomal dominant polycystic kidney disease patients

Hochschulschrift

The polycystin signalling cascade in autosomal dominant polycystic kidney disease

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)

Mortality risk in patients with autosomal dominant polycystic kidney disease

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method

Konferenzschrift | Kongress

Autosomal dominant polycystic kidney disease : 39 tables

Autosomal dominant polycystic kidney disease in Colombia

Echocardiographic characteristics of autosomal dominant polycystic kidney disease

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes

Early clinical management of autosomal recessive polycystic kidney disease

Urine proteome of autosomal dominant polycystic kidney disease patients

Hochschulschrift

The polycystin signalling cascade in autosomal dominant polycystic kidney disease

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)

Mortality risk in patients with autosomal dominant polycystic kidney disease

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method

Autosomal dominant polycystic kidney disease : 39 tables

Autosomal dominant polycystic kidney disease in Colombia

Echocardiographic characteristics of autosomal dominant polycystic kidney disease

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes

Early clinical management of autosomal recessive polycystic kidney disease

Urine proteome of autosomal dominant polycystic kidney disease patients

The polycystin signalling cascade in autosomal dominant polycystic kidney disease

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)

Mortality risk in patients with autosomal dominant polycystic kidney disease

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method

Autosomal dominant polycystic kidney disease : 39 tables

Autosomal dominant polycystic kidney disease in Colombia

Echocardiographic characteristics of autosomal dominant polycystic kidney disease

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes

Early clinical management of autosomal recessive polycystic kidney disease

Urine proteome of autosomal dominant polycystic kidney disease patients

The polycystin signalling cascade in autosomal dominant polycystic kidney disease

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)

Mortality risk in patients with autosomal dominant polycystic kidney disease

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

Estimated GFR in autosomal dominant polycystic kidney disease: errors of an unpredictable method

Autosomal dominant polycystic kidney disease : 39 tables

Autosomal dominant polycystic kidney disease in Colombia

Echocardiographic characteristics of autosomal dominant polycystic kidney disease

To analyse the correlation between UAER and eGFR and the risk factors for reducing eGFR in patients with type 2 diabetes

Early clinical management of autosomal recessive polycystic kidney disease

Urine proteome of autosomal dominant polycystic kidney disease patients

The polycystin signalling cascade in autosomal dominant polycystic kidney disease

Systems biology approaches toward autosomal dominant polycystic kidney disease (ADPKD)

Mortality risk in patients with autosomal dominant polycystic kidney disease

Cellular abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) fibroblasts

Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

Related objects

Reset password